Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Profound Medical (PROF) Shares Outstanding (Diluted Average) (2023 - 2025)

Profound Medical has reported Shares Outstanding (Diluted Average) over the past 3 years, most recently at $30.2 million for Q4 2025.

  • Quarterly results put Shares Outstanding (Diluted Average) at $30.2 million for Q4 2025, up 22.08% from a year ago — trailing twelve months through Dec 2025 was $30.2 million (up 22.08% YoY), and the annual figure for FY2025 was $30.2 million, up 22.08%.
  • Shares Outstanding (Diluted Average) for Q4 2025 was $30.2 million at Profound Medical, roughly flat from $30.1 million in the prior quarter.
  • Over the last five years, Shares Outstanding (Diluted Average) for PROF hit a ceiling of $30.2 million in Q4 2025 and a floor of $21.2 million in Q4 2023.
  • Median Shares Outstanding (Diluted Average) over the past 3 years was $24.8 million (2024), compared with a mean of $26.6 million.
  • Biggest five-year swings in Shares Outstanding (Diluted Average): increased 16.91% in 2024 and later grew 23.65% in 2025.
  • Profound Medical's Shares Outstanding (Diluted Average) stood at $21.2 million in 2023, then increased by 16.91% to $24.8 million in 2024, then increased by 22.08% to $30.2 million in 2025.
  • The last three reported values for Shares Outstanding (Diluted Average) were $30.2 million (Q4 2025), $30.1 million (Q3 2025), and $30.1 million (Q2 2025) per Business Quant data.